Hillstream BioPharma, Inc. (HILS)
NASDAQ: HILS · IEX Real-Time Price · USD
0.600
+0.061 (11.23%)
At close:
Jan 27, 2023, 4:00 PM
0.629
+0.029 (4.90%)
After-hours:
Jan 27, 2023, 7:16 PM EST
Total Valuation
HILS has a market cap or net worth of $6.92 million. The enterprise value is -$678,727.
| Market Cap | 6.92M |
| Enterprise Value | -678,727 |
Important Dates
The next earnings date is Monday, February 13, 2023, before market open.
| Estimated Earnings Date | Feb 13, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
HILS has 11.53 million shares outstanding. The number of shares has increased by 81.40% in one year.
| Shares Outstanding | 11.53M |
| Shares Change (YoY) | +81.40% |
| Shares Change (QoQ) | -0.35% |
| Owned by Insiders (%) | 55.50% |
| Owned by Institutions (%) | 6.28% |
| Float | 3.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.97 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.93
| Current Ratio | 10.93 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -78.00%.
| Return on Equity (ROE) | -78.00% |
| Return on Assets (ROA) | -57.50% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$4.25M |
| Employee Count | 1 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.33% in the last 52 weeks.
| Beta (1Y) | n/a |
| 52-Week Price Change | -84.33% |
| 50-Day Moving Average | 0.44 |
| 200-Day Moving Average | 0.82 |
| Average Volume (30 Days) | 307,552 |
Short Selling Information
The latest short interest is 23,989, so 0.21% of the outstanding shares have been sold short.
| Short Interest | 23,989 |
| Short Previous Month | 10,014 |
| Short % of Shares Out | 0.21% |
| Short % of Float | 0.62% |
| Short Ratio (days to cover) | 0.19 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -5.22M |
| Pretax Income | -4.25M |
| Net Income | -4.25M |
| EBITDA | -2.40M |
| EBIT | -2.40M |
| Earnings Per Share (EPS) | -$0.22 |
Balance Sheet
| Cash & Cash Equivalents | 7.60M |
| Total Debt | n/a |
| Net Cash | 7.60M |
| Net Cash Per Share | $0.66 |
| Equity / Book Value | 7.12M |
| Book Value Per Share | 0.62 |
| Working Capital | 7.12M |
Cash Flow
| Operating Cash Flow | -5.50M |
| Capital Expenditures | n/a |
| Free Cash Flow | -5.50M |
| FCF Per Share | -$0.48 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HILS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -61.49% |
| FCF Yield | -79.53% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -81.40% |
| Shareholder Yield | -81.40% |
Analyst Forecast
The average price target for HILS is $6.12, which is 920.00% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.12 |
| Price Target Difference | 920.00% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |